Consequently, it is assumed that adropin plays a pivotal role in glucose homeostasis and lipid metabolism leading to a reduction in obesity and insulin resistance (IR) [1,4]. Here, ENHO is linked to obesity due to melanocortin 4 receptor deficiency.